You’ll read a lot about precision in this issue of Discovery: Precision diagnosis, precision imaging, precision treatment of localized disease and precision oncology through gene-targeted therapy. Our cover story celebrates an exciting convergence of events: better-than-ever ability to see tiny sites of prostate cancer through PSMA PET, developed here at the Brady by Martin Pomper; breakthrough research that overturns what we all thought we knew about how prostate cancer spreads — and widens our window of curability considerably — and exciting new “spot welding” radiation therapy, being tested in a clinical trial by Phuoc Tran to see if men with oligometastasis can be cured. As always, this issue is packed with stories on the exciting research happening here at the Brady — and as always, I feel like we have barely tapped the surface. There is so much to tell you about, in prostate cancer, and in other cancers, as well. For example, results were so promising from an international study led by Noah Hahn that the FDA has approved a new immunotherapy drug for people with advanced bladder cancer. David McConkey, Director of our Greenberg Bladder Cancer Institute, and colleagues have identified five different molecular subtypes of bladder cancer — precision diagnosis that will lead to precision treatment. More precision diagnoses may be on the way with a “liquid biopsy” for bladder cancer. And in kidney cancer, the American Urological Association has changed its guidelines in large part due to the work of a Brady team led by Mohamad Allaf and Phillip Pierorazio. The new guidelines are based on personalized medicine. That’s our goal for every patient we see here at the Brady: to find the best treatment for that person’s specific disease.
Alan W. Partin, M.D., Ph.D.
The Jakurski Family Director
Professor of Urology
The James Buchanan Brady Urological Institute
Each year, more than 160,000 American men are diagnosed with prostate cancer. The good news is that more men are being cured of this disease than ever before.
Now in a revised fourth edition, this lifesaving guide – Amazon’s #1 Bestseller in Men’s Health for 24 years – by renowned expert Dr. Patrick Walsh and acclaimed science writer Janet Farrar Worthington offers a message of hope to every man facing this illness. Prostate cancer is a different disease in every man—which means that the right treatment varies for each man. Giving you a second opinion from the world’s top experts in surgery, pathology, urology, and radiation and medical oncology, this book helps you determine the best plan for you. Learn:
For additional news and updates from the Brady Institute, please follow us on our web site at urology.jhu.edu or any of our social media sites: Facebook: Brady Urology; Twitter: @brady_urology; bradyurology.blogspot.com